Jupiter Neurosciences (JUNS) Payables (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Payables of $6.6 million for Q4 2025, up 1122.78% year-over-year from $542915.0 in Q4 2024, and up 962.55% quarter-over-quarter from $624784.0 in Q3 2025.
Jupiter Neurosciences (JUNS) Payables (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Payables for 3 consecutive years, with $6.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables rose 1122.78% year-over-year to $6.6 million; the TTM figure through Dec 2025 stood at $6.6 million (up 1122.78% YoY), while the FY2025 annual figure was $6.6 million, up 1122.78% from the prior year.
- Payables climbed to $6.6 million in Q4 2025 per JUNS's latest filing, from $624784.0 in the prior quarter.
- Across five years, Payables topped out at $6.6 million in Q4 2025 and bottomed at $429363.0 in Q1 2025.
- Historically, Payables has averaged $1.7 million across 3 years, with a median of $720396.0 in 2025.
- Annual changes were most pronounced in 2024 — Payables plunged 73.53% — and 2025, when it jumped 1122.78%.
- Jupiter Neurosciences' Payables stood at $2.1 million in 2023, then slumped by 73.53% to $542915.0 in 2024, then surged by 1122.78% to $6.6 million in 2025.
- Business Quant data shows JUNS's Payables at $6.6 million in Q4 2025, $624784.0 in Q3 2025, and $720396.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.64 Mn |
| Sep 30, 2025 | 624,784.00 |
| Jun 30, 2025 | 720,396.00 |
| Mar 31, 2025 | 429,363.00 |
| Dec 31, 2024 | 542,915.00 |
| Sep 30, 2024 | 1.19 Mn |
| Dec 31, 2023 | 2.05 Mn |